Global Immunoprotein Diagnostic Testing Market to reach USD 18.3 billion by 2027

Global Immunoprotein Diagnostic Testing Market Size study, by Type (C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test and Free Light Chain Diagnostic Test), by Application (Autoimmune Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing and Toxicology Testing), by Technology (Radioimmunoassay, Immunoturbidity Assay, Immunoprotein Electrophoresis, Enzyme-linked immunosorbent assay and Others) and Regional Forecasts 2020-2027
Product Code:  HALMD_23179047
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Immunoprotein Diagnostic Testing Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Immunoprotein Diagnostic Testing Market, by Type, 2018-2027 (USD Billion)
1.2.3.	Immunoprotein Diagnostic Testing Market, by Application, 2018-2027 (USD Billion)
1.2.4.	Immunoprotein Diagnostic Testing Market, by Technology, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Immunoprotein Diagnostic Testing Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Immunoprotein Diagnostic Testing Market Dynamics	
3.1.	Immunoprotein Diagnostic Testing Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Immunoprotein Diagnostic Testing Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Immunoprotein Diagnostic Testing Market, by Type          
5.1.	Market Snapshot 
5.2.	Global Immunoprotein Diagnostic Testing Market by Type, Performance - Potential Analysis
5.3.	Global Immunoprotein Diagnostic Testing Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4.	Immunoprotein Diagnostic Testing Market, Sub Segment Analysis
5.4.1.	 C-reactive Protein Diagnostic Test
5.4.2.	Complement System Protein Diagnostic Test
5.4.3.	Pre-albumin Diagnostic Test
5.4.4.	Haptoglobin Diagnostic Test
5.4.5.	Immunoglobulin Diagnostic Test
5.4.6.	Free Light Chain Diagnostic Test
Chapter 6.	Global Immunoprotein Diagnostic Testing Market, by Application          
6.1.	Market Snapshot 
6.2.	Global Immunoprotein Diagnostic Testing Market by Application, Performance - Potential Analysis
6.3.	Global Immunoprotein Diagnostic Testing Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4.	Immunoprotein Diagnostic Testing Market, Sub Segment Analysis
6.4.1.	 Autoimmune Testing
6.4.2.	Infectious Disease Testing
6.4.3.	Allergy Testing
6.4.4.	Endocrine Testing
6.4.5.	Oncology Testing
6.4.6.	Toxicology Testing
Chapter 7.	Global Immunoprotein Diagnostic Testing Market, by Technology          
7.1.	Market Snapshot 
7.2.	Global Immunoprotein Diagnostic Testing Market by Technology, Performance - Potential Analysis
7.3.	Global Immunoprotein Diagnostic Testing Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
7.4.	Immunoprotein Diagnostic Testing Market, Sub Segment Analysis
7.4.1.	 Radioimmunoassay
7.4.2.	Immunoturbidity Assay
7.4.3.	Immunoprotein Electrophoresis
7.4.4.	Enzyme-linked immunosorbent assay
7.4.5.	Others
Chapter 8.	Global Immunoprotein Diagnostic Testing Market, Regional Analysis
8.1.	Immunoprotein Diagnostic Testing Market, Regional Market Snapshot 
8.2.	North America Immunoprotein Diagnostic Testing Market 
8.2.1.1.	U.S. Immunoprotein Diagnostic Testing Market 
8.2.1.2.	Type breakdown estimates & forecasts, 2017-2027
8.2.1.3.	Application breakdown estimates & forecasts, 2017-2027
8.2.1.4.	Technology breakdown estimates & forecasts, 2017-2027
8.2.2.	Canada Immunoprotein Diagnostic Testing Market
8.3.	Europe Immunoprotein Diagnostic Testing Market Snapshot
8.3.1.	U.K. Immunoprotein Diagnostic Testing Market 
8.3.2.	Germany Immunoprotein Diagnostic Testing Market
8.3.3.	France Immunoprotein Diagnostic Testing Market
8.3.4.	Spain Immunoprotein Diagnostic Testing Market
8.3.5.	Italy Immunoprotein Diagnostic Testing Market
8.3.6.	Rest of Europe Immunoprotein Diagnostic Testing Market
8.4.	Asia-Pacific Immunoprotein Diagnostic Testing Market Snapshot
8.4.1.	China Immunoprotein Diagnostic Testing Market 
8.4.2.	India Immunoprotein Diagnostic Testing Market 
8.4.3.	Japan Immunoprotein Diagnostic Testing Market
8.4.4.	Australia Immunoprotein Diagnostic Testing Market
8.4.5.	South Korea Immunoprotein Diagnostic Testing Market
8.4.6.	Rest of Asia Pacific Immunoprotein Diagnostic Testing Market
8.5.	Latin America Immunoprotein Diagnostic Testing Market Snapshot
8.5.1.	Brazil Immunoprotein Diagnostic Testing Market
8.5.2.	Mexico Immunoprotein Diagnostic Testing Market
8.6.	Rest of The World Immunoprotein Diagnostic Testing Market

Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	Abbott Laboratories 
9.2.1.1.	Key Information
9.2.1.2.	Overview
9.2.1.3.	Financial (Subject to Data Availability)
9.2.1.4.	Product Summary
9.2.1.5.	Recent Developments
9.2.2.	 Abcam PLC
9.2.3.	Bio-Rad Laboratories
9.2.4.	Danaher Corporation
9.2.5.	Diasorin, Enzo Life Sciences
9.2.6.	Ortho Clinical Diagnostics
9.2.7.	Roche Diagnostics
9.2.8.	Siemens Healthcare
9.2.9.	Thermo Fisher Scientific
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Immunoprotein Diagnostic Testing Market is valued approximately at USD 10.1 billion in 2019 and is anticipated to grow with a growth rate of more than 6.6% over the forecast period 2020-2027. Immunoprotein diagnostic testing detects the level of immunoproteins in the body such as, pre-albumin, immunoglobulin, among others. With the growing incidences & prevalence of infectious and chronic diseases such as diabetes, heart disease, arthritis, kidney disease etc., rise in geriatric population, and growth in demand for early diagnostic services is likely to propel the immunoprotein diagnostic testing market. For instance: according to AgeingAsia.org, the number of people aged 60 and above were 11,988,000 in 2019 and is expected to rise by 29,841,000 in 2050. Also, the total percentage of population aged 60 and above were 12.3% in 2019 and is expected to rise by 27.2 % in 2050. Also, as per Statista, the American geriatric population (65 years old or more) was 16% in 2018 and is anticipated to rise by 22% of American geriatric population in 2050. Also, the global adult population suffered from diabetes in 2019 was around 9.3% and is expected to rise by 11% in 2045. Also, according to the United Nations, Department of Economic & Social Affairs, there were 703 million persons aged 65 years or over in the world in 2019 and is projected to double to 1.5 billion in 2050. Whereas, stringent regulations are the major factor restraining the growth of global Immunoprotein Diagnostic Testing market during the forecast period.

The regional analysis of global Immunoprotein Diagnostic Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the increase in demand for quick diagnostic services to detect chronic diseases, ongoing trend of preventive healthcare, and rise in the number of drug abuse and allergy cases. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Abbott Laboratories
Abcam PLC
Bio-Rad Laboratories
Danaher Corporation
Diasorin, Enzo Life Sciences
Ortho Clinical Diagnostics
Roche Diagnostics
Siemens Healthcare
Thermo Fisher Scientific

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Type:
C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Pre-albumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobulin Diagnostic Test
Free Light Chain Diagnostic Test

by Application:
Autoimmune Testing
Infectious Disease Testing
Allergy Testing
Endocrine Testing
Oncology Testing
Toxicology Testing

By Technology:
Radioimmunoassay
Immunoturbidity Assay
Immunoprotein Electrophoresis
Enzyme-linked immunosorbent assay
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Immunoprotein Diagnostic Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…